ANTHEM — Anthem BioSciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapHigh Flyer

Annual balance sheet for Anthem BioSciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,499	6,180	8,357	6,434	7,331
Net Total Accounts Receivable
Net Total Receivables	2,570	3,335	2,753	4,906	4,599
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6,158	10,933	13,232	14,816	17,367
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,736	4,759	6,039	8,210	9,981
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	10,337	16,189	20,145	23,981	28,076
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,849	2,262	1,639	3,386	3,262
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	3,323	2,639	2,738	4,735	3,977
Common Stock
Other Equity
Total Equity	7,015	13,550	17,407	19,247	24,099
Total Liabilities & Shareholders' Equity	10,337	16,189	20,145	23,981	28,076
Total Common Shares Outstanding